|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||198.92 - 201.00|
|52 Week Range||160.93 - 217.62|
|PE Ratio (TTM)||10.98|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||231.75|
Yahoo Finance is the exclusive online host of the Berkshire Hathaway 2018 Annual Shareholders Meeting, coming Saturday, May 5th.
Berkshire Hathaway (BRK/B), the well-known Warren Buffett investment vehicle for the last 50 years, has been the subject of many good notes and discussions. In this note I will briefly cover general background and then discuss a few key topics as to why NOT to buy BRK, and will try to defend my thesis. General background BRK’s business model is unique.
The Zacks Analyst Blog Highlights: AbbVie, Berkshire Hathaway, PepsiCo, BP and Twenty-First Century Fox
Berkshire Hathaway’s (BRK.B) investment portfolio grew to $191 billion in 4Q17 on an increase in its stakes in existing companies and a rise in the valuations of its holdings. In 1Q18, the company is expected to see its investment portfolio valuation fall, as major holdings have seen erosion in the range of 3%–22%. Berkshire could also look to add stakes at their current valuations, as lower prices are offering better valuations.
The Trump administration has initiated a trade war with its allies and China by levying duties on imported goods in order to protest unfair trade practices. President Donald Trump has indicated that he will prolong the war until China opens up to the import of goods and services and doesn’t resort to controlled currency strategy in order to boost exports. In the initial round of levying duties, China has countered the United States with 25% import duties.